SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+17.66%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(+6.9%)
Cap. Flow
-$60.9M
Cap. Flow
% of AUM
-25.61%
Top 10 Holdings %
Top 10 Hldgs %
90.75%
Holding
25
New
6
Increased
6
Reduced
6
Closed
6
Top Buys
| 1 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$8.91M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$8.67M |
| 3 |
Galapagos
GLPG
|
$8.65M |
| 4 |
ADMA Biologics
ADMA
|
$7.53M |
| 5 |
Evolus
EOLS
|
$4.76M |
Top Sells
| 1 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$55M |
| 2 |
QuidelOrtho
QDEL
|
$17.3M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$9.32M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$8.57M |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$4.42M |
Sector Composition
| 1 | Healthcare | 98.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $46.2M | 19.45% | 6,333,239 +105,506 | +2% | +$770K |
|
|
APEN
2
DELISTED
Apollo Endosurgery, Inc.
APEN
| $37.2M | 15.63% | 3,726,584 +893,953 | +32% | +$8.91M |
|
|
CTIC
3
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $29.7M | 12.47% | 4,934,100 -735,288 | -13% | -$4.42M |
|
|
4
ADMA Biologics
ADMA
$4.12B
| $26.9M | 11.33% | 6,940,000 +1,940,000 | +39% | +$7.53M |
|
|
5
QuidelOrtho
QDEL
$1.95B
| $25.7M | 10.81% | 300,000 -201,633 | -40% | -$17.3M |
|
6
Xeris Biopharma Holdings
XERS
$1.26B
| $14.9M | 6.26% | 11,195,189 -1,732,979 | -13% | -$2.3M |
|
7
UroGen Pharma
URGN
$900M
| $11.6M | 4.87% | 1,304,947 +180,727 | +16% | +$1.6M |
|
|
THRD
8
DELISTED
Third Harmonic Bio
THRD
| $8.67M | 3.65% | +2,015,301 | New | +$8.67M |
|
|
9
Galapagos
GLPG
$2.07B
| $8.65M | 3.64% | +194,836 | New | +$8.65M |
|
|
10
Evolus
EOLS
$494M
| $6.27M | 2.64% | 834,432 +634,432 | +317% | +$4.76M |
|
11
Rezolute
RZLT
$619M
| $6.25M | 2.63% | 3,021,504 +48,299 | +2% | +$100K |
|
12
Castle Biosciences
CSTL
$696M
| $4.2M | 1.77% | +178,240 | New | +$4.2M |
|
|
CFMS
13
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.48M | 1.05% | 748,194 -16,556,156 | -96% | -$55M |
|
14
Mirum Pharmaceuticals
MIRM
$3.71B
| $2.12M | 0.89% | +108,769 | New | +$2.12M |
|
15
Exagen
XGN
$217M
| $2.05M | 0.86% | 854,042 -411,331 | -33% | -$987K |
|
16
MaxCyte
MXCT
$148M
| $1.49M | 0.63% | +273,287 | New | +$1.49M |
|
17
OmniAb
OABI
$230M
| $1.28M | 0.54% | +354,266 | New | +$1.28M |
|
18
Xoma
XOMA
$392M
| $1.19M | 0.5% | 64,459 | – | – |
|
|
OPTN
19
DELISTED
OptiNose
OPTN
| $940K | 0.4% | 508,284 -1,491,716 | -75% | -$2.76M |
|
|
AFMD
20
DELISTED
Affimed
AFMD
| – | – | -1,979,828 | Closed | -$4.08M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| – | – | -8,547,965 | Closed | -$9.32M |
|
|
22
Ligand Pharmaceuticals
LGND
$3.15B
| – | – | -99,562 | Closed | -$8.57M |
|
23
Ovid Therapeutics
OVID
$91M
| – | – | -1,540,671 | Closed | -$2.83M |
|
|
ATYR
24
aTyr Pharma
ATYR
$527M
| – | – | -600,980 | Closed | -$1.8M |
|
|
OPNT
25
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| – | – | -152,278 | Closed | -$1.64M |
|